NewList your AI tool for $19 $49. Paste a URL and AI drafts the listing.Submit a tool →Already listed? Claim it free.Claim your tool →

Paige AI

AI-powered pathology applications for cancer detection and biomarker discovery

16KMonthly visits
20Popularity
Paige AI featured image

About Paige AI

Paige develops AI technology for cancer care, focusing on pathology workflows and molecular biomarker discovery from tissue samples. The company provides diagnostic AI applications that assist in cancer detection, subtyping, and biomarker identification using H&E-stained whole-slide images. Paige’s offerings include specialized suites for prostate, breast, gastrointestinal, and pan-cancer applications, all built on foundation models trained on large datasets. These AI tools are designed to support pathologists by reducing workload pressures while maintaining diagnostic quality. In addition to diagnostic applications, Paige licenses its foundation models and provides custom AI development services, regulatory strategy, and commercialization support for life sciences organizations.

Key features

  • Prostate cancer detection and diagnosis on H&E slides
  • Breast cancer identification and classification
  • Gastrointestinal tract pathology support
  • Pan-cancer biomarker identification
  • Foundation models for AI development
  • Custom AI model development services
  • Regulatory strategy and commercialization support
  • Multi-modal co-pilot for pathologists

Use cases

  • Cancer detection and diagnosis in pathology labs
  • Molecular biomarker discovery for therapeutic targeting
  • Development of AI-powered pathology applications

Pros

  • Foundation models trained on over 1.5 million slides
  • Specialized AI suites for multiple cancer types
  • Supports biomarker discovery directly from tissue samples
  • Provides custom AI development and regulatory services
  • Multi-modal co-pilot for pathology workflows

Cons

  • No free tier or public API access mentioned
  • Focused exclusively on cancer pathology
  • Requires licensing for most advanced features
  • Limited to tissue-based diagnostics

Frequently asked questions about Paige AI

What is Paige AI and what does it do?

Paige AI develops AI technology specifically for cancer care, focusing on pathology workflows and molecular biomarker discovery from tissue samples. The company provides diagnostic AI applications that assist in cancer detection, subtyping, and biomarker identification using H&E-stained whole-slide images.

Who is Paige AI designed for?

Paige AI is designed for pathologists and life sciences organizations, including those in clinical diagnostics, research, and drug development. Its tools support cancer detection, classification, and biomarker discovery to improve diagnostic efficiency and accuracy.

What are Paige AI's foundation models?

Paige offers foundation models such as Virchow, Virchow2, Virchow2G, and PRISM, which are trained on large datasets of tissue samples. These models power diagnostic applications and can be licensed for custom AI development in computational pathology.

What diagnostic AI applications does Paige provide?

Paige provides specialized AI suites for prostate, breast, gastrointestinal, and pan-cancer applications. These include tools like Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige PanCancer Suite, all designed to assist pathologists in cancer detection and diagnosis.

How does Paige Alba work?

Paige Alba is a multi-modal co-pilot that integrates AI with voice and text commands to streamline pathology workflows. It provides real-time insights and optimized workflows to support cancer detection and diagnosis, built on Paige’s diagnostic and biomarker applications.

Can Paige AI's technology be customized for specific needs?

Yes, Paige offers custom AI development services, including the development of prognostic or predictive applications, regulatory strategy, and commercialization support. Organizations can license Paige’s foundation models to build tailored AI solutions for their research and development goals.

Paige AI traffic & engagement

paige.ai · third-party estimates from Similarweb

Data as of Sep 2026Full AI website ranking →
Monthly visits · Sep 202616K+27.5% MoM12-month high 28K (Jun 2026)
Rank among AI websites#3,899▲ 259 vs last monthof 8,652 tools on aitoolnavio™
Rank in Lifestyle & Education#264of 667 tools in this category
Top marketUnited States82.6%Top 5 countries bring 100% of visits
Average visit1m 56sLonger than 76% of AI sites
Pages per visit4.74More than 90% of AI sites
Bounce rate27%Lower than 96% of AI sites
Similarweb global rank#1,183,177#408,405 in United States

Traffic trend

Last 4 months · grows by one month every month

  • Jun 202628K
  • Jul 202621K−24.8%
  • Aug 202612K−39.8%
  • Sep 202616K+27.5%

Where visitors come from

Share of visits by channel

  • Direct71%
  • Search17.9%
  • Referrals9.9%
  • Mail0.9%
  • Social0.3%

No measurable traffic from Paid Referrals.

Top countries

Share of visits · estimated visits

  • United States13K82.6%
  • Italy9065.7%
  • Brazil8595.4%
  • Philippines5253.3%
  • India3982.5%

Traffic figures are third-party estimates, good for scale and trends; they can differ from a company's own numbers. Updated monthly.

Reviews